Insider Trading Alert - SEIC, OPK And DCI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, March 31, 2014, 69 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,500.00 to $189,613,554.86.

Highlighted Stocks Traded by Insiders:

SEI Investments Company (SEIC) - FREE Research Report

Lieb Richard who is Director at SEI Investments Company sold 20,000 shares at $33.52 on March 31, 2014. Following this transaction, the Director owned 200,985 shares meaning that the stake was reduced by 9.05% with the 20,000-share transaction.

The shares most recently traded at $33.76, up $0.23, or 0.7% since the insider transaction. Historical insider transactions for SEI Investments Company go as follows:

  • 4-Week # shares sold: 186,045
  • 12-Week # shares sold: 211,045
  • 24-Week # shares sold: 562,045

The average volume for SEI Investments Company has been 812,100 shares per day over the past 30 days. SEI Investments Company has a market cap of $5.7 billion and is part of the financial sector and financial services industry. Shares are down 3.22% year-to-date as of the close of trading on Monday.

SEI Investments Co. is a publicly owned investment manager. The firm provides wealth management and investment advisory services to its clients through its subsidiaries. The stock currently has a dividend yield of 1.31%. The company has a P/E ratio of 20.4. Currently there are 2 analysts that rate SEI Investments Company a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SEIC - FREE

TheStreet Quant Ratings rates SEI Investments Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, impressive record of earnings per share growth, compelling growth in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full SEI Investments Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 37,700 shares at $8.88 on March 31, 2014. Following this transaction, the CEO & Chairman owned 139.8 million shares meaning that the stake was reduced by 0.03% with the 37,700-share transaction.

The shares most recently traded at $9.30, up $0.42, or 4.5% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 3.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.7 billion and is part of the health care sector and health services industry. Shares are up 10.43% year-to-date as of the close of trading on Monday.

Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 4 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Donaldson Company (DCI) - FREE Research Report

Perushek Mary Lynne who is Vice President at Donaldson Company sold 1,430 shares at $42.24 on March 31, 2014. Following this transaction, the Vice President owned 33,819 shares meaning that the stake was reduced by 4.06% with the 1,430-share transaction.

The shares most recently traded at $42.52, up $0.28, or 0.66% since the insider transaction.

The average volume for Donaldson Company has been 391,000 shares per day over the past 30 days. Donaldson Company has a market cap of $6.1 billion and is part of the industrial goods sector and industrial industry. Shares are down 2.44% year-to-date as of the close of trading on Monday.

Donaldson Company, Inc. manufactures and sells filtration systems and replacement parts. The company operates in two segments, Engine Products and Industrial Products. The stock currently has a dividend yield of 1.33%. The company has a P/E ratio of 24.2. Currently there are no analysts that rate Donaldson Company a buy, 2 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DCI - FREE

TheStreet Quant Ratings rates Donaldson Company as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and increase in stock price during the past year. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Donaldson Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

"Strong Case for More Rate Hikes" Says Fed Chair Jerome Powell

"Strong Case for More Rate Hikes" Says Fed Chair Jerome Powell

Disney Tops Comcast Bid With Improved $71.3 Billion Approach for Fox

Disney Tops Comcast Bid With Improved $71.3 Billion Approach for Fox

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

European Union Says Tariffs on U.S. Imports Will Kick In on June 22